Avalo Therapeutics, Inc. ($AVTX)
Filing Information
| Accession Number | 0001677896-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | May 7, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
225,189
Total Value
$2,454,054.66
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | May 6, 2026 | Exercise/Conversion | 62,500 | $13.43 | $839,375.00 | 66,134 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | May 6, 2026 | Exercise/Conversion | 12,563 | $8.04 | $101,006.52 | 78,697 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | May 6, 2026 | Sale | 37,375 | $18.91 | $706,836.00 | 41,322 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | May 6, 2026 | Sale | 5,196 | $19.78 | $102,783.12 | 36,126 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | May 6, 2026 | Sale | 22,839 | $21.22 | $484,540.80 | 13,287 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | May 6, 2026 | Sale | 9,253 | $22.70 | $210,029.22 | 4,034 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | May 6, 2026 | Sale | 400 | $23.71 | $9,484.00 | 3,634 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | May 6, 2026 | Exercise/Conversion | 62,500 | $0.00 | $0.00 | 87,500 | Direct | โ | View Details | |
Chief Legal Officer | Stock Option (Right to Buy) | Derivative | May 6, 2026 | Exercise/Conversion | 12,563 | $0.00 | $0.00 | 87,437 | Direct | โ | View Details |